Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00651872 · ClinicalTrials.gov registry record
Development and Validation of a PTSD-Related Functional Impairment Scale
A clinical trial of Stress Disorders, Post-Traumatic, sponsored by Boston VA Research Institute.
- Completed
- Registry status
- 740
- Enrollment target
- 2
- Study locations
NCT00651872: Completed study of Stress Disorders, Post-Traumatic, sponsored by Boston VA Research Institute.
NCT00651872 is a study of Stress Disorders, Post-Traumatic that has completed, run by Boston VA Research Institute. The registered enrollment target is 740 participants, above the 145-participant average among 66 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (410% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00651872, a study of Stress Disorders, Post-Traumatic, has completed, sponsored by Boston VA Research Institute.
- COMPLETED
- Registry status
- 740 participants
- Enrollment target
- 2
- Study locations
Study Summary
This project has the long-term goal of designing and validating a psychometrically sound inventory of PTSD-related functional impairment for active duty service members and veterans. The inventory will include assessments of multiple dimensions of functional impairment and their impact on quality of life and explicitly show how PTSD symptoms are related to functional impairment. By creating and validating an inventory to assess PTSD-related functioning--as they are perceived and reported by active military personnel and veterans--we hope to offer a useful tool for clinicians, researchers and military leaders. A measure of PTSD-related functional impairment will have enormous value from a health care perspective in terms of identifying individuals with the disorder and for promoting more efficient allocation of resources and efforts towards those who are in most need. We anticipate that the end product of this study, an efficient, empirically-based measure of PTSD-related functional impairment will have an immediate impact on the assessment and treatment of military-related PTSD, in terms of promoting more efficient allocation of resources and efforts towards those who are in most need. Such a measure will also assist with PTSD-related compensation and pension procedures and decisions by providing a means to more accurately assess PTSD-related functional impairment.
Conditions Studied
Study Locations (2)
Maryland
- Walter Reed Army Institute of Research - Silver Springs
Massachusetts
- VA Boston Healthcare System (Jamaica Plain Campus) - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 740 participants |
| Start Date | 2008-06 |
| Est. Completion | 2013-06 |
What the finished NCT00651872 record still lists
NCT00651872 is an observational study that tracks outcomes without assigning an intervention. The registered 740 participants enrollment target is mid-sized for trials with a published cap, above the 145-participant average among 66 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (410% higher).
The record links to 1 condition, with Stress Disorders, Post-Traumatic appearing as the primary indexed condition, and to 0 interventions.
NCT00651872 reports a single indexed study location in Maryland, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00651872 about?
NCT00651872 is a clinical study titled "Development and Validation of a PTSD-Related Functional Impairment Scale". This project has the long-term goal of designing and validating a psychometrically sound inventory of PTSD-related functional impairment for active duty service members and veterans. The inventory will include assessments of multiple dimensions of functional impairment and their impact on quality of...
What is the current status of trial NCT00651872?
This trial is currently completed. The enrollment target is 740 participants. The study started on 2008-06. Estimated completion is 2013-06.
What conditions does trial NCT00651872 study?
This clinical trial studies the following conditions: Stress Disorders, Post-Traumatic.
Who is sponsoring clinical trial NCT00651872?
This trial is sponsored by Boston VA Research Institute, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00651872 being conducted?
This trial has 2 study locations across Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress Disorders, Post-Traumatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00651872's enrollment target sits among peer trials
740 4th of 66 higher than 63 of 66 other Stress Disorders, Post-Traumatic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress Disorders, Post-Traumatic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Manage Emotions to Reduce Aggression (MERA)
RECRUITING · NA
-
SMART Therapist Training: A Hybrid Factorial-SMART Design
RECRUITING · NA
-
Overcontrol and Suicide in PTSD
RECRUITING
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
-
Healthy Recovery After Trauma Study
RECRUITING · NA
-
MDMA for Co-occurring PTSD and OUD After Childbirth
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03963622 · 740 participants · NA
Careful Ventilation in Acute Respiratory Distress Syndrome (COVID-19 and Non-COVID-19)
- NCT04074135 · 740 participants · Phase 2
Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors
- NCT05215340 · 740 participants · Phase 3
Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations
- NCT06172478 · 740 participants · Phase 2
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia